CLINICAL_TRIALS
trial_result
· 2025-07-25
Clinical Trial Update: Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease [Phase 2]
Summary
A Phase 2 trial evaluating MGTA-145 in combination with Plerixafor for sickle cell disease was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ensoma | Conditions: Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-07-25